Association between <i>MAP3K</i> alterations and clinical outcome.
- Lorenzo Ferrando (6648539)
- Andrea Vingiani (8204229)
- Anna Garuti (212195)
- Claudio Vernieri (9744243)
- Antonino Belfiore (155199)
- Luca Agnelli (207773)
- Gianpaolo Dagrada (5754221)
- Diana Ivanoiu (14322304)
- Giuseppina Bonizzi (9528557)
- Elisabetta Munzone (5958338)
- Luana Lippolis (14322307)
- Martina Dameri (10979993)
- Francesco Ravera (12545903)
- Marco Colleoni (6393845)
- Giuseppe Viale (173594)
- Luca Magnani (167833)
- Alberto Ballestrero (212236)
- Gabriele Zoppoli (201733)
- Giancarlo Pruneri (384238)
Publication date
January 2023
DOI Publisher
Public Library of Science (PLoS)Abstract
Kaplan Meier curves displaying distant relapse-free survival (DRFS) (A) and overall survival (OS) (B) in patients with MAP3K gene alteration (red curves) as compared with patients with wild-type MAP3K status (blue curves). Forest plots indicating the hazard ratios for DRFS (C) and OS (D), and the corresponding confidence intervals, in MAP3K-altered and MAP3K-wild type patients. Multivariable Cox analysis is adjusted for tumor size, lymph node involvement, Ki67, menopausal status and tumor grade of the primary tumor.</p
Add to ORKG